Natural killer cells activated by MHC class ILow targets prime dendritic cells to induce protective CD8 T cell responses

Immunity

Volumn 19, Issue 4, 2003, Pages 561-569

  Mocikat, Ralph ^a   Braumüller, Heidi ^b,c   Gumy, Alain ^d   Egeter, Oliver ^c   Ziegler, Heike ^e   Reusch, Uwe ^e   Bubeck, Anja ^e   Louis, Jacques ^d   Mailhammer, Reinhard ^a   Riethmüller, Gert ^e   Koszinowski, Ulrich ^e   Röcken, Martin ^b,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; MEMORY CELL; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 10744220243     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00264-4     Document Type: Article

References (34)

1. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Immunol. Today. 21:2000;447-455.
2. Biedermann T., Zimmermann S., Himmelrich H., Gumy A., Egeter O., Sakrauski A.K., Seegmüller I., Voigt H., Launois P., Levine A.D.et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2:2001;1054-1060.
3. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense. function and regulation by innate cytokines Annu. Rev. Immunol. 329:1999;189-220.
4. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 292:2001;934-937.
5. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413:2001;165-170.
6. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2:2001;951-956.
7. Egeter O., Mocikat R., Ghoreschi K., Dieckmann A., Röcken M. Eradication of disseminated lymphomas with CpG-DNA-activated Th1 cells from non-transgenic mice. Cancer Res. 60:2000;1515-1520.
8. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:2002;343-351.
9. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:2002;327-333.
10. Glas R., Franksson L., Une C., Eloranta M.-L., Öhlén C., Örn A., Kärre K. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses J. Exp. Med. 191:2000;129-138.
11. Hayakawa Y., Kelly J.M., Westwood J.A., Darcy P.K., Diefenbach A., Raulet D., Smyth M.J. Cutting edge. tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin J. Immunol. 169:2002;5377-5381.
12. Höglund P., Sundback J., Olsson-Alheim M.Y., Johansson M., Salcedo M., Öhlén C., Ljunggren H.G., Sentman C.L., Kärre K. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol. Rev. 155:1997;11-28.
13. Ikeda H., Old L.J., Schreiber R.D. The roles of IFN gamma in protection against tumor development and cancer immunoeditiing. Cytokine Growth Factor Rev. 13:2002;95-109.
14. Kägi D., Ledermann B., Burki K., Zinkernagel R.M., Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:1996;207-232.
15. Kärre K., Ljunggren H.G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319:1986;675-678.
16. Kelly J.M., Darcy P.K., Markby J.L., Godfrey D.I., Takeda K., Yagita H., Smyth M.J. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3:2002;83-90. a.
17. Kelly J.M., Takeda K., Darcy P.K., Yagita H., Smyth M.J. A role for IFN-γ in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J. Immunol. 168:2002;4472-4479. b.
18. Kirberg J., Baron A., Jakob S., Rolink A., Karjalainen K., von Boehmer H. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180:1994;25-34.
19. Knabel M., Franz T.J., Schiemann M., Wulf A., Villmow B., Schmidt B., Bernhard H., Wagner H., Busch D.H. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat. Med. 8:2002;631-635.
20. Krmpotic A., Messerle M., Crnkovic-Mertens I., Polic B., Jonjic S., Koszinowski U. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. J. Exp. Med. 190:1999;1285-1295.
21. Lanier L.L. NK cell receptors. Annu. Rev. Immunol. 16:1998;359-393.
22. Long E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:1999;875-904.
23. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods. 145:1991;185-192.
24. Matzinger P. The danger model. a renewed sense of self Science. 296:2002;301-305.
25. Medzhitov R., Janeway C.A. Decoding the patterns of self and nonself by the innate immune system. Science. 296:2002;298-300.
26. Mocikat R., Selmayr M., Thierfelder S., Lindhofer H. Trioma-based vaccination against B cell lymphoma confers long-lasting tumor immunity. Cancer Res. 57:1997;2346-2349.
27. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:2001;197-223.
28. Piccioli D., Sbrana S., Melandri E., Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195:2002;335-341.
29. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science. 290:2000;84-89.
30. Selmayr M., Strehl J., Kremer J.-P., Kremmer E., Doenecke A., Hallek M., Menzel H., Thielemans K., Thierfelder S., Mocikat R. Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype. Gene Ther. 6:1999;778-784.
31. Tanaka T., Kitamura F., Nagasaka Y., Kuida K., Suwa H., Miyasaka M. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J. Exp. Med. 178:1993;1103-1107.
32. Xu X.N., Screaton G.R., McMichael A.J. Virus infections. escape, resistance and counterattack Immunity. 15:2001;867-870.
33. Ziegler H., Thale R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., Koszinowski U.H. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity. 6:1997;57-66.
34. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 195:2002;F9-F14.